GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BetterLife Pharma Inc (XCNQ:BETR) » Definitions » Earnings Yield (Joel Greenblatt) %

BetterLife Pharma (XCNQ:BETR) Earnings Yield (Joel Greenblatt) % : -26.46% (As of Oct. 2023)


View and export this data going back to 2017. Start your Free Trial

What is BetterLife Pharma Earnings Yield (Joel Greenblatt) %?

BetterLife Pharma's Enterprise Value for the quarter that ended in Oct. 2023 was C$10.44 Mil. BetterLife Pharma's EBIT for the trailing twelve months (TTM) ended in Oct. 2023 was C$-2.76 Mil. BetterLife Pharma's Earnings Yield (Joel Greenblatt) for the quarter that ended in Oct. 2023 was -26.46%.

The historical rank and industry rank for BetterLife Pharma's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:

XCNQ:BETR' s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -525.94   Med: 0   Max: 1250
Current: -18.21

During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of BetterLife Pharma was 1250.00%. The lowest was -525.94%. And the median was 0.00%.

XCNQ:BETR's Earnings Yield (Joel Greenblatt) % is ranked worse than
55.75% of 1417 companies
in the Biotechnology industry
Industry Median: -15.65 vs XCNQ:BETR: -18.21

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. BetterLife Pharma's Forward Rate of Return (Yacktman) % for the quarter that ended in Oct. 2023 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.


BetterLife Pharma Earnings Yield (Joel Greenblatt) % Historical Data

The historical data trend for BetterLife Pharma's Earnings Yield (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BetterLife Pharma Earnings Yield (Joel Greenblatt) % Chart

BetterLife Pharma Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Earnings Yield (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -30.86 -75.76 -51.55 -63.69 -52.08

BetterLife Pharma Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Earnings Yield (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -65.79 -52.08 -57.47 -63.29 -26.46

Competitive Comparison of BetterLife Pharma's Earnings Yield (Joel Greenblatt) %

For the Biotechnology subindustry, BetterLife Pharma's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BetterLife Pharma's Earnings Yield (Joel Greenblatt) % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BetterLife Pharma's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where BetterLife Pharma's Earnings Yield (Joel Greenblatt) % falls into.



BetterLife Pharma Earnings Yield (Joel Greenblatt) % Calculation

In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.

BetterLife Pharmas Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Jan. 2023 is calculated as

Earnings Yield (Joel Greenblatt)=EBIT/Enterprise Value
=-9.306/17.889585
=-52.02 %

BetterLife Pharma's EBIT for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-2.76 Mil.



BetterLife Pharma  (XCNQ:BETR) Earnings Yield (Joel Greenblatt) % Explanation

Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.

Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.


Be Aware

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.


BetterLife Pharma Earnings Yield (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of BetterLife Pharma's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


BetterLife Pharma (XCNQ:BETR) Business Description

Industry
Traded in Other Exchanges
Address
1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6
BetterLife Pharma Inc a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus, and/or to directly inhibit tumors to treat various types of cancer.
Executives
Ahmad Doroudian Director, Senior Officer